David Gryska
Net worth: 722 967 $ as of 2026-10-30
Net worth: 722 967 $ as of 2026-10-30
David W.
Gryska is currently an Independent Director at Definium Therapeutics, Inc. since 2023 and at Celcuity, Inc. starting in 2026.
Former positions include President, CEO, COO, and Director at Myrexis, Inc. in 2012; Independent Director at Seagen, Inc. from 2005 to 2023; Independent Director at Forte Biosciences, Inc. from 2023 to 2026; Independent Director at Aerie Pharmaceuticals, Inc. from 2018 to 2022 and Director there from 2012 to 2015; Lead Independent Director at Hyperion Therapeutics, Inc. from 2012 to 2014; Director at GW Pharmaceuticals Ltd. from 2020 to 2021; Independent Director at Coimmune from 2012 to 2014; Independent Director at PDL BioPharma, Inc. from 2014 to 2020; Chief Financial Officer and Executive Vice President at Incyte Corp.
from 2014 to 2018; Chief Financial Officer and Senior Vice President at Celgene Corp.
from 2006 to 2010; Chief Financial Officer and Senior Vice President at Scios, Inc. from 2000 to 2004; Chief Financial Officer and Vice President-Finance at Cardiac Pathways Corp.
from 1993 to 1998; Principal at Strategic Consulting Group, Inc. from 2004 to 2006; Director roles at Phenomix Corp., CoTherix, Inc., Medpace, Inc.; and Audit Partner at Ernst & Young LLP.
Education includes an MBA from Golden Gate University and undergraduate studies at Loyola University of Chicago.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 19,900 ( 0.01% ) | 722 967 $ | 2026-10-30 |
| Companies | Position | Start |
|---|---|---|
| DEFINIUM THERAPEUTICS, INC. | Director/Board Member | 2023-06-20 |
| CELCUITY INC. | Director/Board Member | 2026-09-30 |
| Companies | Position | End |
|---|---|---|
| FORTE BIOSCIENCES | Director/Board Member | 2026-08-26 |
| SEAGEN INC. | Director/Board Member | 2023-12-13 |
| AERIE PHARMACEUTICALS, INC. | Director/Board Member | 2022-11-20 |
| GW PHARMACEUTICALS PLC | Director/Board Member | 2021-05-04 |
| PDL BIOPHARMA, INC. | Director/Board Member | 2020-12-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 21 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Cardiac Pathways Corp.
Cardiac Pathways Corp. Medical SpecialtiesHealth Technology Designs, develops and manufactures cardiac diagnosis systems | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
Hyperion Therapeutics, Inc.
Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Myrexis, Inc.
Myrexis, Inc. Financial ConglomeratesFinance Engages in identifying, evaluating and making financial investments in life sciences assets | Finance |
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of cannabinoid-based prescription medicines | Commercial Services |
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Golden Gate University
Golden Gate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that provides antibody development services | Health Technology |
Medpace, Inc.
Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services to the pharmaceutical, biotech and medical industries | Commercial Services |
Strategic Consulting Group, Inc.
Strategic Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management and M&A consulting services | Commercial Services |
Celcuity, Inc.
Celcuity, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company develops novel diagnostic tests | Health Technology |
Mind Medicine (MindMed), Inc.
Mind Medicine (MindMed), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company which develops novel products to treat brain health disorders | Health Technology |
Forte Biosciences, Inc.
Forte Biosciences, Inc. BiotechnologyHealth Technology Provides dermatological therapies and related services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions